These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
898 related items for PubMed ID: 7581095
21. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination. Carlens S, Ringdén O, Aschan J, Hägglund H, Ljungman P, Mattsson J, Remberger M. Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394 [Abstract] [Full Text] [Related]
22. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft. Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F. Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557 [Abstract] [Full Text] [Related]
23. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L. Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [Abstract] [Full Text] [Related]
24. Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia. Kato K, Yoshida N, Matsumoto K, Matsuyama T. Pediatr Blood Cancer; 2014 Apr; 61(4):712-6. PubMed ID: 24376191 [Abstract] [Full Text] [Related]
25. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide. Bostrom B, Weisdorf DJ, Kim T, Kersey JH, Ramsay NK. Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007 [Abstract] [Full Text] [Related]
26. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen. Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J. Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682 [Abstract] [Full Text] [Related]
27. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens. Woods WG, Ramsay NK, Weisdorf DJ, Haake R, Vallera DA, Kim TH, Lasky L, Nesbit ME, Bostrom B, Uckun F. Bone Marrow Transplant; 1990 Jul; 6(1):9-16. PubMed ID: 2202462 [Abstract] [Full Text] [Related]
28. Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. Talano JM, Casper JT, Camitta BM, Keever-Taylor CA, Murray KJ, Eapen M, Pierce KL, Margolis DA. Bone Marrow Transplant; 2006 Jan; 37(2):135-41. PubMed ID: 16273115 [Abstract] [Full Text] [Related]
29. [Allogeneic hematopoietic stem cell transplantation for acute lymphocytic leukemia]. Chen H, Ren HY, Guo NL, Huang XJ, Liu KY, Xu LP, Zhang YC, Zheng H, Wu T, Liu DH, Yang SM, Lu DP. Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):87-90. PubMed ID: 14990046 [Abstract] [Full Text] [Related]
30. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Al-Kasim FA, Thornley I, Rolland M, Lau W, Tsang R, Freedman MH, Saunders EF, Calderwood S, Doyle JJ. Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456 [Abstract] [Full Text] [Related]
31. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Singhal S, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Mehta J. Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368 [Abstract] [Full Text] [Related]
32. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. Singhal S, Powles R, Treleaven J, Horton C, Swansbury GJ, Mehta J. Bone Marrow Transplant; 1996 Dec; 18(6):1049-55. PubMed ID: 8971372 [Abstract] [Full Text] [Related]
33. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission. Blaise D, Gaspard MH, Stoppa AM, Michel G, Gastaut JA, Lepeu G, Tubiana N, Blanc AP, Rossi JF, Novakovitch G. Bone Marrow Transplant; 1990 Jan; 5(1):7-12. PubMed ID: 2404531 [Abstract] [Full Text] [Related]
34. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation. Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S. Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323 [Abstract] [Full Text] [Related]
35. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients. Cahn JY, Bordigoni P, Souillet G, Pico JL, Plouvier E, Reiffers J, Benz-Lemoine E, Bergerat JP, Lutz P, Colombat P. Bone Marrow Transplant; 1991 Jan; 7(1):1-4. PubMed ID: 2043871 [Abstract] [Full Text] [Related]
36. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan. Carpenter PA, Marshall GM, Giri N, Vowels MR, Russell SJ. Bone Marrow Transplant; 1996 Sep; 18(3):489-94. PubMed ID: 8879607 [Abstract] [Full Text] [Related]
37. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, Granena A, Gahrton G, De Witte T, Gratwohl A, Reiffers J, Gorin NC. Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048 [Abstract] [Full Text] [Related]
38. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC). Houtenbos I, Bracho F, Davenport V, Slack R, van de Ven C, Suen Y, Killen R, Shen V, Cairo MS. Bone Marrow Transplant; 2001 Jan; 27(2):145-53. PubMed ID: 11281383 [Abstract] [Full Text] [Related]
39. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Marks DI, Forman SJ, Blume KG, Pérez WS, Weisdorf DJ, Keating A, Gale RP, Cairo MS, Copelan EA, Horan JT, Lazarus HM, Litzow MR, McCarthy PL, Schultz KR, Smith DD, Trigg ME, Zhang MJ, Horowitz MM. Biol Blood Marrow Transplant; 2006 Apr; 12(4):438-53. PubMed ID: 16545728 [Abstract] [Full Text] [Related]
40. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants. Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, Dipersio J, Adkins D. Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]